Product information

Current status:

Marketed

Current status date:

2024-06-03

Original market date: ^{See footnote 1}

2024-06-03

Product name:

AMB-BISACODYL

DIN:

02520478 Electronic product monograph is not available

Company:

AMBICARE PHARMACEUTICALS INC.
302 1670 North Service Road East
Oakville
Ontario
Canada L6H 7G3

Class:

Human

Dosage form(s):

Suppository

Route(s) of administration:

Rectal

Number of active ingredient(s):

1

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

56:12.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

A06AB02 BISACODYL

Active ingredient group (AIG) number:^{See footnote5}

0101506002